Tripartite Therapeutics
Tripartite is an ADC innovator with hydrophilic payload(s) and hydrophilic oligosaccharide linker. Tripartite’s technology platforms and payload library help create world-class ADCs that:
- Minimize systemic and liver toxicities while staying in and killing the tumor cell due to hydrophilic payload(s).
- Achieve deep tumor penetration with antibody-mediated specific bystander effect via endosomal recycling of intact ADCs.
- Reap the efficacy of high DAR~8 for any antibody or payload.
- Realize synergistic effects of dual-payload ADCs.
